Germany, April 2 -- Germany based neuraxpharm Arzneimittel GmbH has secured contract from Vergabekammer des Bundes beim Bundeskartellamt for Pharmaceutical products Announcement of orders awarded according to 130 c SGB V for the drug Ublituximab Briumvi. The value of the contract is not disclosed.
Published by HT Digital Content Services with permission from Pivotal Sources....